Alps Advisors Inc Taro Pharmaceutical Industries LTD Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$78.25 - $107.92 $5.46 Million - $7.53 Million	-69,773 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$97.82 - $116.09 $1.16 Million - $1.38 Million	11,849 Added 20.46%	69,773 $6.86 Million
Q2 2018 Aug 02, 2018	BUY	$97.62 - $120.59 $1.27 Million - $1.57 Million	13,031 Added 29.03%	57,924 $6.7 Million
Q2 2018 Jul 25, 2018	SELL	$97.62 - $120.59 $868,134 - $1.07 Million	-8,893 Reduced 16.53%	44,893 $4.7 Million
Q1 2018 May 01, 2018	BUY	$95.91 - $107.26 $852,927 - $953,863	8,893 Added 19.81%	53,786 $5.31 Million
Q4 2017 Feb 05, 2018	BUY	$104.5 - $126.38 $521,977 - $631,268	4,995 Added 12.52%	44,893 $4.7 Million
Q3 2017 Nov 03, 2017	BUY	$97.26 - $116.2 $3.88 Million - $4.64 Million	39,898	39,898 $4.5 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.